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Ashok K. Chockalingam,a Danielle Hickman,a Lindomar Pena,a Jianqiang Ye,a Andrea Ferrero,a Jose R. Echenique,b Hongjun Chen,a
Troy Sutton,a and Daniel R. Pereza
Department of Veterinary Medicine, University of Maryland, College Park, Maryland, USA,a and Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas,
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We investigated the synergism between influenza virus and Streptococcus pneumoniae, particularly the role of deletions in the
stalk region of the neuraminidase (NA) of H2N2 and H9N2 avian influenza viruses. Deletions in the NA stalk (NA) had no ef-
fect on NA activity or on the adherence of S. pneumoniae to virus-infected human alveolar epithelial (A549) andmouse lung ade-
noma (LA-4) cells, although it delayed virus elution from turkey red blood cells. Sequential S. pneumoniae infection of mice pre-
viously inoculated with isogenic recombinant H2N2 and H9N2 influenza viruses displayed severe pneumonia, elevated levels of
intrapulmonary proinflammatory responses, and death. No differences between theWT andNAmutant viruses were detected
with respect to effects on postinfluenza pneumococcal pneumonia as measured by bacterial growth, lung inflammation, morbid-
ity, mortality, and cytokine/chemokine concentrations. Differences were observed, however, in influenza virus-infected mice
that were treated with oseltamivir prior to a challenge with S. pneumoniae. Under these circumstances, mice infected withNA
viruses were associated with a better prognosis following a secondary bacterial challenge. These data suggest that the H2N2 and
H9N2 subtypes of avian influenza A viruses can contribute to secondary bacterial pneumonia and deletions in the NA stalk may
modulate its outcome in the context of antiviral therapy.
Influenza virus infection in humans usually leads to a brief illnessthat varies in severity, depending on multiple viral and host
factors. Fatalities are often linked to secondary infections with
bacterial pathogens. Streptococcus pneumoniae is among the most
important bacterial pathogens associated with postinfluenza
pneumonia, and it is the leading cause of community-acquired
pneumonia in humans (1, 34). S. pneumoniae bacteria are com-
mensals of the human respiratory tract and colonize up to 70% of
individuals without causing clinical symptoms.
Several factors have been proposed to contribute to viral-
bacterial synergism, including dysfunctional neutrophils and al-
veolar macrophages, increased bacterial adherence to the epithe-
lium due to upregulation of cryptic receptor expression on its
surface, and influenza virus-induced immunosuppression (16).
The neuraminidase (NA) protein of influenza A viruses is one of
the viral factors identified in this viral-bacterial synergism (17, 21,
22). The specific NA activities of representative humanH2N2 and
H3N2 subtype viruses isolated from 1957 to 1997 correlated with
their abilities to cause secondary bacterial infections (22). Except
for the 1918 pandemic H1N1 subtype, the mortality and second-
ary bacterial pneumonia rates have been higher following H3N2
infections than following H1N1 infections, suggesting an impor-
tant role for the N2 subtype in this regard (17, 21, 22).
The influenza virus NA is a type II membrane glycoprotein
found on the viral surface along with the hemagglutinin (HA)
glycoprotein (5). NA promotes the release of the virus from in-
fected cells and prevents HA-mediated virus self-aggregation by
cleaving off sialic acids of viral and cellular glycoconjugates (36).
The NA stalk region varies considerably in length, even within the
same subtypes, and plays a role in replication and pathogenesis
(13). Deletions in the NA stalk are characteristic of the adaptation
of influenza viruses from aquatic birds and poultry, particularly
chickens (19, 29). Variations in the NA stalk have been shown to
play a role in the virulence of highly pathogenic H5N1 avian in-
fluenza viruses (38). Recently, we showed that adaptingH2N2 and
H9N2 avian influenza A viruses isolated from wild waterfowl to
quail and chickens resulted in significant deletions in the NA stalk
region and increased replication in both chickens and mice
(8, 29).
Wild aquatic birds are the reservoirs of all known subtypes of
influenza A viruses, and some of these are occasionally transmit-
ted to poultry species. The H9N2 subtype is endemic to poultry in
many Eurasian countries and has occasionally caused clinical
respiratory diseases in humans (2, 20).H2N2 viruses were respon-
sible for the emergence of the 1957 influenza pandemic. Phyloge-
netic analysis of avian H2N2 influenza viruses has revealed little
antigenic divergence from the 1957 pandemic H2N2 strain. Inter-
regional transmission of H2 viruses between North America and
Eurasia has been documented (12, 24). Based on the genetic and
transmissibility characteristics of bothH2N2 andH9N2 viruses, it
is possible that the surface genes of these viruses could reassort
with human influenza viruses, creating reassortants with pan-
demic potential. It has been recently shown that reassortant vi-
ruses derived from the H9N2 and 2009 pandemic H1N1 strains
were able to be transmitted efficiently in ferrets and some were
more pathogenic inmice than the parental viruses were (9, 32). In
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this study, we determined whether the length of the stalk region of
N2 NAs from avian H2N2 and H9N2 viruses has an effect in pro-
moting secondary bacterial infection in the mouse model.
MATERIALS AND METHODS
Viruses. Mouse-adapted influenza virus A/Puerto Rico/8/1934 (H1N1)
(PR8) was used as a control and to create viruses with isogenic back-
grounds. Quail- and chicken-adapted viruses (WT and NA H2N2, re-
spectively) carrying full-length and 27-amino-acid (aa) deletions in the
NA stalk region, respectively, have been previously described and were
derived from the A/mallard/Potsdam/178-4/1983 (H2N2) virus (29).
Quail- and chicken-adapted viruses (WT and NA H9N2, respectively)
with full-length and 21-aa deletions in the NA stalk region, respectively,
were previously described andwere derived from theA/duck/HongKong/
702/1979 (H9N2) virus (8, 28). Recombinant viruses with theHA andNA
(WT and NA) gene segments of avian viruses with an isogenic back-
ground from the PR8 virus were generated by reverse genetics (7) (Table
1). The HA, NA, andM genes were sequenced to confirm the identities of
the viruses recovered. Viruses were grown in embryonated chicken eggs,
and the allantoic fluid was collected, aliquoted, titrated in Madin-Darby
canine kidney cells (50% tissue culture infective doses [TCID50]) and eggs
(50% egg infective dose [EID50]), and stored at80°C until used.
Pneumococci. S. pneumoniae D39, a type 2 encapsulated strain, was
grown at 37°C in tryptic soy broth (TSB; Difco Laboratories, Detroit, MI)
supplemented with 5%CO2 for 6 h or until log phase. The bacterium was
mixed with 15% glycerol and frozen at80°C. The pneumococcus con-
centrationwasmeasured by determining the absorbance at 600 nmandby
quantitation on TSB agar supplemented with 3% (vol/vol) sheep erythro-
cytes (Lampire Biologicals, Pipersville, PA).
Bacterial adherence assay.Human lung carcinoma A549 andmurine
lung LA-4 cells (ATCC, Manassas, VA) were seeded at 5  105/well into
24-well plates (Costar, Corning Inc., Corning, NY). An adhesion assay
was performed as described previously, with minor modifications (17).
Briefly, the cells were infected with influenza viruses at a multiplicity of
infection of 1 at 37°C for 1 h and then incubated with 10 CFU/cell of
pneumococci for 2 h at 37°C. The cell monolayers were washed to re-
move loosely adherent pneumococci, incubated with 1 trypsin-EDTA
(Sigma-Aldrich, St. Louis, MO) to detach the cells from the plate, and
finally lysed using 0.025% Triton X-100 (Sigma-Aldrich). Control cells
were treated identically without the addition of virus. The cell lysates were
serially diluted 10-fold in phosphate-buffered saline (PBS) and plated on
tryptic soy agar (Sigma-Aldrich) supplemented with 3% (vol/vol) sheep
erythrocytes to determine the number of bacterial cells adhering to the cell
monolayers.
NA activity assay. Viruses were grown in eggs, concentrated by ultra-
centrifugation at 35,000 rpm for 2 h at 4°C, and further purified by using
10 to 40% discontinuous sucrose gradients. The purified virus was resus-
pended in NTE buffer (100 mM NaCl, 10 mM Tris-Cl [pH 7.4], 1 mM
EDTA). The protein concentration in purified virus samples was mea-
sured by determining the A280 using a NanoDrop spectrophotometer
(Thermo Scientific, Waltham, MA). Equal amounts of purified viral pro-
teins were serially diluted 2-fold in MES assay buffer [32.5 mM 2-(N-
morpholino)ethanesulfonic acid, 4 mM CaCl2, pH 6.5] and allowed
to react with 10 M 2=-(4-methylumbelliferyl)-N-acetylneuraminic
acid (Mu-NANA) substrate (Sigma-Aldrich). The fluorescence of
4-methylumbelliferone cleaved from the Mu-NANA substrate was mea-
sured on aVictorVmultilabel plate reader (Perkin-Elmer,Waltham,MA)
with 355- and 460-nm excitation and emission filters, respectively. NA
activity was also measured by using the NA-Star influenza virus NA in-
hibitor resistance detection kit (Applied Biosystems, Foster City, CA) and
following the manufacturer’s recommendations.
Virus elution assay. The ability of viruses to be eluted from erythro-
cytes was determined as described previously (3). Briefly, viruses were
serially diluted in calcium saline buffer (6.8 mM CaCl2, 150 mMNaCl in
20mMborate buffer, pH7.2) and incubatedwith 50l of 0.5% chicken or
turkey erythrocytes (Lampire Biologicals) at 4°C for 1 h in microtiter
plates. Then the plates were transferred to 37°C, and the reduction of HA
titers was monitored periodically for 24 h.
Postinfluenza S. pneumoniaemouse challenge. Six-week-old female
BALB/c mice were obtained from Charles River Laboratories (Frederick,
MD) and maintained under animal biosafety level 2 conditions in the
Department of Veterinary Medicine. Animal studies were conducted un-
der protocols R-09-93 and R-10-65 and were approved by the Institu-
tional Animal Care and Use Committee of the University of Maryland,
College Park. Mice were handled under general anesthesia with inhaled
2.5% isoflurane (Abbot Laboratories, North Chicago, IL). Mouse 50%
lethal doses (MLD50s) were determined as previously described (23), us-
ing groups of mice (n 3) infected with serial dilutions (101 to 107) of
the viral stocks.
Influenza viruses (0.5 MLD50) were administered intranasally in a
volume of 50 l to anesthetized mice held in an upright position. Virus-
infected mice were challenged at 7 days postinfection (dpi) with 102, 103,
104, or 105 CFU of pneumococci per mouse. For experiments involving
therapeutic treatment of influenza virus-infectedmice with commercially
available oseltamivir (Tamiflu; Hoffman-La Roche, Nutley, NJ), mice
were given oseltamivir at a dose of 10 mg/kg/day twice a day for 5 days by
oral gavage starting at 48 h postinfection (hpi). Oseltamivir treatment was
stopped on the day that mice were challenged with S. pneumoniae (104
CFU/mouse).
Mice were weighed and monitored daily for disease signs and death.
Mice that lost25%of their bodyweightwere euthanized and considered
dead on that day. At 7 dpi and at 1 and 3 days post-pneumococcal chal-
lenge (dppc), lungs were collected; homogenates were prepared and used
to determine viral and bacterial titers.
Cytokine and chemokine analysis. Mouse lung homogenates col-
lected at 1 dppc were centrifuged at 5,000 rpm for 15 min at 4°C, and the
supernatants were frozen at 80°C until analyzed. Concentrations of
interleukin-1 (IL-1), IL-6, IL-10, tumor necrosis factor alpha (TNF-),
and the chemokines KC and macrophage inflammatory protein 1 alpha
(MIP-1) were measured by using a mouse 6-Plex Luminex-100 system
(Cytokine Core Laboratory, University of Maryland School of Medicine,
Baltimore, MD).
Histopathology. At 7 dpi and 2 dppc, mice were bled and euthanized
and their lungs were removed (2 mice/group). The lungs were fixed in
10% neutral buffered formalin. Lung tissues were embedded in paraffin,
sectioned at 5 m, and stained with hematoxylin and eosin (H&E). A
board-certified veterinary pathologist who was blinded to the groups ex-
amined the slides. Lung tissue sections were examinedmicroscopically for
histopathological alterations and the presence of inflammation in the lung
parenchyma and airways.
Statistical analysis. The data are expressed as arithmetic means 
standard errors. An unpaired Student t test was performed to determine
the level of significance of differences between the means of two groups.
Cytokine and chemokine levels of groups were compared by analysis of
variance (ANOVA) with Bonferroni’s posttest correction to determine
which groups had significant differences. Survival data of groups of mice
were compared with the log rank (Mantel-Cox) test. P values of 0.05
were considered significant. All statistical analyses were donewith Prism 5
software (GraphPad Software Inc., La Jolla, CA).
TABLE 1 Titers of viruses and their virulence in mice
Virusa TCID50 (log10/ml) EID50 (log10/ml) MLD50 (log10 EID50)
A/PR/8/34 9.192 10.199 2.565
WT H2N2 9.342 10.199 6.231
NA H2N2 8.899 9.949 5.648
WT H9N2 9.699 9.949 6.315
NA H9N2 9.342 9.449 5.815
a Viruses contain the same set of internal gene segments derived from the PR8 strain.
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Adherence of S. pneumoniae to virus-infected human and mu-
rine lung epithelial cells.The level of S. pneumoniae adherence to
epithelial cells depends upon the degree of NA activity of different
influenza A viruses (22). We have previously adapted duck H2N2
and H9N2 avian influenza viruses to quail and chickens. The re-
sulting strains contained deletions in the stalk region of NA
(NA) that favor viral replication in chickens. TheNAs ofH2N2
andH9N2 viruses have 27- and 21-aa deletions in the stalk region,
respectively (8, 29). To test the effect of NA length on the adher-
ence of S. pneumoniae to cultured cells, we infected human A549
and murine LA-4 cells with influenza A virus and then superin-
fected themwith bacteria. After 2 h of incubation at 37°C, the level
of adhesion of S. pneumoniae to virus-infected A549 and LA-4
cells was increased compared to the level of adhesion to mock-
infected cells (Fig. 1A and B, respectively). The levels of pneumo-
coccal adhesion to A549 and LA-4 cells were similar for theH2N2,
H9N2, and PR8 strains. Additionally, there were no significant
differences in the adhesion of pneumococci between the WT and
NA strains, suggesting that NA length plays no role in S. pneu-
moniae adhesion in vitro.
Stalk deletions in N2 NA affects elution of virus bound to
turkey erythrocytes. NAs with a short stalk were found to be
inefficient at releasing progeny virions, which may be caused by
the active site having limited access to the substrate (6). The NA
activity in purified virus preparations of WT and NA mutant
H2N2 and H9N2 strains were measured using the Mu-NANA
substrate and compared to that of the control PR8 virus. The WT
and NA strains had similar levels of NA activity in both avian
virus subtypes (Fig. 1C).We also found the sameNAactivity using
FIG 1 Bacterial adherence is increased in influenza virus-infected A549 and LA-4 cells. A549 (A) and LA-4 (B) cells were infected with PR8,WT, andNA avian
influenzaAH2N2orH9N2 virus ormock infected and then infectedwith S. pneumoniae strainD39 (Sp). Levels of bacterial adhesion are expressed as percentages
of the level measured in mock-infected cells (the level of bacterial adherence to mock-infected cells was set at 100% [not shown]). The results are displayed as
means and ranges (not standard deviations) of six (A549 cells) and three (LA-4 cells) consecutive independent experiments with four replicates in each
experiment. No statistically significant differences were found. (C)NA activities of avian influenza A viruses. TheNA activities of concentrated and purified PR8,
WT, andNA avian influenza AH2N2 andH9N2 viruses weremeasured by aMu-NANA substrate fluorescence assay. NA activities are expressed as percentages
of the activity of A/PR/8/34 (H1N1) NA, which was arbitrarily set at 100%. The data are displayed as means and ranges of three independent experiments
containing four replicates of each virus. Differences in NA activity are not statistically significant. (D, E) WT and NAmutant avian viruses differ in the ability
to elute from erythrocytes. Twofold dilutions of virus containing 1:128 HA units were incubated with equal volumes of 0.5% chicken (D) or turkey (E)
erythrocytes at 4°C for 1 h. The reduction in HA units was recorded for 24 h after incubation at 37°C.
Chockalingam et al.
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a different method, the NA star influenza virus NA inhibitor re-
sistance detection kit (data not shown).
Previous studies showed thatNA stalk length affects the elution
of viruses bound to erythrocytes, but there was no correlation
betweenNA stalk length and enzymatic activity with large (fetuin)
and/or small (sialyllactose) substrates (3, 6). We performed virus
elution assays using chicken and turkey erythrocytes. From
chicken erythrocytes, the WT viruses showed 4- to 8-fold reduc-
tions in HA units in a span of 24 h of incubation at 37°C, whereas
the corresponding NA viruses showed an only 2-fold reduction
(Fig. 1D).Whenwe used turkey erythrocytes, theWT viruses were
more efficiently eluted, with a 128-fold reduction inHAunits. The
NA strain elution was delayed and produced only 4- to 8-fold
reductions during the same 24-h period (Fig. 1E). Taken together,
these results suggest that NA deletions in avian H2N2 and H9N2
viruses result in delayed virus release from erythrocytes, possibly
due to differences in the sialic acid milieu on the surfaces of dif-
ferent cells.
PostinfluenzaS.pneumoniae challengeofmice results in sec-
ondary pneumonia independent of NA stalk length. In order to
study the viral-bacterial synergism in the mouse model, recombi-
nant influenza viruses that differed only in the HA and NA gene
segments were rescued with the six internal gene segments from
the PR8 virus. All of the recombinant viruses grew to high titers in
embryonated chicken eggs and caused morbidity and death in
mice (Table 1). The EID50s of all of the recombinant viruses were
similar to that of the parental PR8 virus. TheMLD50 of the recom-
binant viruses with avian influenza virus HA and NA genes re-
quired 3 to 4 log10 more virus than the mouse-adapted parental
PR8 strain, which is probably due to the fact that the H2N2 and
H9N2 surface proteins are not well adapted to replicate in mice.
No significant differences in the EID50 and MLD50 titers were
observed for the WT NA and NA N2 recombinant viruses.
BALB/c mice were infected with 0.5 MLD50 of influenza virus
and challenged at 7 dpi with 102, 103, 104, or 105 CFU of S. pneu-
moniae (Fig. 2). Mice were monitored for changes in body weight
and disease signs for 21 dpi (14 dppc; graphs show only up to 10
dppc). In the PR8 virus-infected group, there was no change in
body weight after virus inoculation; however, after pneumococcal
infection, mice exhibited a 20% body weight loss when large
bacterial doses were administered (Fig. 2A). Mice in the WT and
NA (H2N2 and H9N2) groups started losing body weight at 3
dpi and continued to lose 10 to 20% of their body weight until a
pneumococcal challenge (Fig. 2B to E). Interestingly, the NA
(H2N2 and H9N2) groups showed a more pronounced body
weight loss prior to challenge than the WT NA counterparts did,
although the mechanism behind this effect remains unknown. A
rough coat, reduced activity, and reduced body weight were more
pronounced after pneumococcal infection in all of the previously
infected groups. Disease signs did not differ significantly between
the WT and NA groups. No significant differences in mouse
survival were observed in these groups either, irrespective of both
the length of the NA gene and the bacterial dose (Fig. 2F to J).
Significantmortality was observed at 2 dppc with 105 CFU inmice
that previously received the WT or NA H2N2 virus or the NA
H9N2 virus, whereas those that received the WT H9N2 virus
showed comparatively delayed death (Fig. 2G to J).
Viral titers were determined in the lungs of virus-infectedmice
at 7 dpi and at 1 and 3 dppc. In the PR8 virus-only and PR8-S.
pneumoniae groups, virus titers of 105 TCID50/g of tissue were
detected at 7 dpi and 1 dppc; however, at 3 dppc, the viral titers
were either low or undetectable in these two groups (not shown).
No virus titers above the limit of detection (0.7 log10 TCID50/g)
were observed at 7 dpi and 1 dppc in mice infected with the avian
WT and NA recombinant viruses (data not shown). With re-
spect to the bacterial load, significantly higher titers (CFU/g of
tissue) were found in the lungs of mice that were previously in-
fected with influenza viruses than in controls infected with bacte-
ria alone (Fig. 3). These results show that influenza virus infection
increased pneumococcal colonization and facilitated the replica-
tion of S. pneumoniae in the lower respiratory tract. The lungs of
mouse groups that were challenged with either 102 or 103 CFU of
bacteria after virus infection showed 1 to 2 log10 reductions in
pneumococcal titers at 3 dppc versus 1 dppc (Fig. 3A to D). Sig-
nificant bacterial load variations were observed at 3 dppc in
groups that were challengedwith 102CFU (Fig. 3B). In contrast, at
1 dppc, lungs contained up to 108 CFU/g of tissue, irrespective of
the bacterial challenge dose (Fig. 3A, C, E, and F) and no signifi-
cant differences between the WT and NA recombinant viruses
were observed. No pneumococcal load was determined at 3 dppc
in the groups challenged with 104 and 105 CFU of bacteria due to
significant mortality at 2 dppc.
Cytokine and chemokine responses are exacerbated in
postinfluenza S. pneumoniae challenge mice. To determine the
pulmonary cytokine and chemokine responses during secondary
bacterial pneumonia following influenza virus infection, the con-
centrations of TNF-, IL-1, IL-6, IL-10, KC, and MIP-1 in
mouse lung homogenates were measured. The levels of cytokines
and chemokines at 1 dppc in the lungs of mice mock infected or
infected with S. pneumoniae alone were similar to each other (Fig.
4). Increased cytokine responses were evident in PR8-infected
mice (10-fold compared to controls); however, they were exac-
erbated following a bacterial challenge (20- to 1,000-fold, depend-
ing on the cytokine, at 1 dppc compared to negative controls).
Consistent with this observation, there was also exacerbation of
cytokine responses in the WT and NA virus groups after a chal-
lenge with pneumococci (1 dppc, Fig. 4). Significant increases in
the levels of IL-1, IL-6, TNF-, KC, and MIP-1 were observed
after a bacterial challenge in mice previously infected with influ-
enza virus compared to those in mock-infected controls. How-
ever, only levels of IL-1, IL-6, and TNF- were significantly in-
creased compared to those in PR8-infected controls not bacterial
challenged. Of note, there were significant variations in the levels
of the anti-inflammatory cytokine IL-10. There was an approxi-
mately 6-fold increase in IL-10 expression in mice infected with
PR8 virus alone compared to that in either negative controls or
controls infected with bacteria alone. The IL-10 response in-
creased another 2-fold in PR8 mice challenge with pneumococci,
whichwas found to be statistically significant (10-fold over basal
levels). A similar pattern was observed in the H9N2-S. pneu-
moniae group. However, the WT and NA H2N2 recombinant
virus groups and the NA H9N2 group showed no exacerbated
expression of IL-10 following a secondary bacterial challenge
compared to the control group given PR8 virus alone. Significant
MIP-1 increases were observed after a bacterial challenge inmice
previously infected with PR8 and either the WT or NA H9N2
virus but not with either theWT orNAH2N2 virus. These stud-
ies suggest HA subtype-dependent effects which can modulate
cytokine responses during infection and affect the response to a
Inﬂuenza Virus-Streptococcus pneumoniae Synergism
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FIG 2 Postinfluenza secondary pneumococcal pneumonia-induced morbidity and mortality in mice. Groups of mice (n 5) were infected with 0.5 MLD50 of
PR8 virus or WT or NAmutant H2N2 and H9N2 recombinant viruses carrying a PR8 isogenic background. Control mice were mock infected with PBS. Mice
were then challenged at 7 dpi with different doses of pneumococci. The percentage of body weight lost, as a measure of morbidity (A to E), and survival (F to J)
was plotted. Error bars indicate standard deviations. Control mice receiving only PBS or pneumococci had no weight loss, and 100% survived (data not shown).
The differences observedwithin and between theWT andNAmutant viruses at different bacterial challenge dose levels are not statistically significant by the log
rank (Mantel-Cox) test. Sp, S. pneumoniae.
Chockalingam et al.
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bacterial challenge. Understanding such mechanisms is beyond
the scope of the present report.
Histopathological studiesof coinfectedmouse lungs are con-
sistent with secondary bacterial bronchopneumonia.To under-
stand the severity of the lung inflammatory response to secondary
S. pneumoniae in mice primed with avian H2N2 and H9N2 vi-
ruses, histopathological changes in lung sectionswere examined at
7 dpi and 2 dppc. At 7 dpi, the lungs in the PR8 virus-infected
mouse group showed mild inflammation and minimal necrosis
and hyperplasia of the bronchiolar and alveolar epithelium (Fig.
5A). The mice infected with both WT and NA recombinant vi-
ruses had mild-to-moderate hyperplasia and inflammation of the
bronchiolar and alveolar epithelium along with infiltration of
lymphocytes and macrophages (Fig. 5B to E). The lesions in the
lung parenchymaweremore widespread inmice infected with the
PR8 and H2N2 recombinant viruses (Fig. 5A to C) than in their
H9N2-infected counterparts (Fig. 5D and E). At 2 dppc, lungs
from mock-infected mice had normal histopathological features
(not shown). Lungs of mock-infectedmice challenged with pneu-
mococci had few foci of macrophages and neutrophils in the peri-
bronchiolar region at 2 dppc (Fig. 5F). PR8-infected (virus-only
control) mice had minimal necrosis and inflammation in the
bronchiolar, peribronchiolar, and alveolar regions of the lung
parenchyma at 7 dpi (Fig. 5G). In contrast, lungs of mice virus
infected and then bacterially challenged showed severe inflamma-
tory responses consistent with secondary pneumococcal pneumo-
nia (Fig. 5H to L). The H2N2-S. pneumoniae and H9N2-S.
pneumoniae groups (Fig. 5H to K) were characterized by mild-to-
moderate hyperplasia of the bronchiolar epithelium, severe and
diffuse inflammation of the lobes, suppurative fibrinous pleuritis,
and the presence of inflammatory cells (neutrophils and macro-
phages). The pneumonic process extended to the pleura, resulting
in marked pleuritis. These observations are similar to those of the
lungs of the PR8-S. pneumoniae mouse group, which showed
moderate necrotizing bronchitis and severe diffuse alveolar in-
flammation (Fig. 5L). No difference in the severity of inflamma-
FIG 3 Pulmonary bacterial loads during secondary bacterial infection. Mice (n  5) were infected with the indicated viruses and challenged at 7 dpi with S.
pneumoniae (102 [A and B], 103 [C and D], 104 [E], or 105 [F] CFU/mouse). Lung bacterial titers were measured at 1 and 3 dppc and are expressed as CFU/g of
lung homogenate. No statistically significant differences between the bacterial loads of the WT and NA mutant virus groups were observed.
Inﬂuenza Virus-Streptococcus pneumoniae Synergism
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tion between the WT and NA virus groups was observed. How-
ever, consistent with the lack of exacerbated IL-10 responses, the
severity of inflammation was higher in the WT H2N2, NA
H2N2, and NA H9N2 groups than in the WT NA H9N2 group.
Oseltamivir treatment improves the prognosis of secondary
bacterial infection in mice previously infected with NA vi-
ruses.Anti-influenza drug therapy is thought to lessen the chance
of a secondary bacterial infection and therefore improve the prog-
nosis of influenza virus infections (15). We studied whether the
therapeutic administration of oseltamivir to virus-infected mice
would reduce the impact of secondary bacterial pneumonia in
terms of morbidity and mortality. Oseltamivir treatment was ini-
tiated at 48 hpi and continue for the next 5 days (Fig. 6). On the
last day of antiviral therapy, mice were challenge with pneumo-
cocci (104 CFU/mouse). Consistent with a previous report (15),
PR8-infected mice that were treated with oseltamivir did not lose
body weight and showed reduced pneumococcal CFU counts at 1
dppc (compare Fig. 3E and 6C) and the mice survived (n  4).
NAmutant virus-infected, oseltamivir-treatedmice showed im-
proved survival compared to nontreated mice (80 to 100% [Fig.
6B] compared to 20 to 40% [Fig. 2H and J]).However, oseltamivir
treatment of WT H2N2 and H9N2 virus-infected mice did not
improve their survival significantly (compare Fig. 6B with Fig. 2G
and I). Bacterial loads at 1 dppc showed more variations in mice
previously treated with oseltamivir (Fig. 6C) than did those of
mice that did not receive antiviral treatment (Fig. 3E). Also, a
significant bacterial load decrease was observed in theNAH9N2
group that received oseltamivir treatment compare to a similar
group that had been previously infected with theWTH9N2 virus.
Histopathological analyses at 2 dppc were consistent with the sur-
vival results, with mice in the PR8-S. pneumoniae group showing
normal lungs and those in the WT H9N2-S. pneumoniae group
showing the most severe lung lesions, similar to those of un-
treated, WT H9N2-S. pneumoniae-infected mice (data not
shown). Other groups showed mild-to-moderate hyperplasia in
the bronchial epithelium and focalized moderate-to-severe inter-
stitial inflammation of the alveoli (data not shown). These results
suggest that therapeutic treatment with oseltamivir has the poten-
tial to improve the survival of secondary bacterial pneumonia,
although there are factors that may influence its effectiveness.
DISCUSSION
Influenza virus infection and its complications are among the
leading causes of morbidity and mortality worldwide. Influenza
virus infections are expressed clinically as primary viral pneumo-
nias and acute respiratory distress syndrome and are occasionally
associatedwith secondary bacterial pneumonia due to superinfec-
tion with bacterial pathogens. With the exceptions of the 1918
pandemic and H5N1 avian influenza viruses, primary viral pneu-
monia is not the major cause of death (34). In general, influenza
virus infection can induce bronchitis and pneumonia, but severe
lethal pneumonia is usually seen when complications involve bac-
terial infections. Superinfection with S. pneumoniae, Staphylococ-
cus aureus, or Haemophilus influenzae has been well documented
during influenza pandemics and epidemics and was shown to be a
typical cause of death (16). Although, in general, influenza A vi-
ruses can induce secondary bacterial pneumonia, excess mortality
appears to be subtype dependent (26, 35, 37). The viral NA is one
FIG 4 Postinfluenza S. pneumoniae (Sp) infection exacerbates pulmonary cytokine and chemokine levels. Mice (n 5) were infected with the indicated viruses
and challenged at 7 dpi with 105 CFU of S. pneumoniae. Lung homogenates were collected at 1 dppc and assayed for cytokine concentrations. Cytokine levels for
each group are represented as means and ranges. *, **, and *** denote statistically significant differences of P  0.05, P  0.01, and P  0.001, respectively,
determined by one-way ANOVA (compared to the group infected with PR8 virus alone).
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of the virulence factors that cause this difference in excess mortal-
ity (17, 22). Studies of several human viruses within the N2 sub-
type isolated from 1957 to 1997 have shown that differences inNA
activity correlated with their abilities to cause secondary bacterial
infections (22). It has been speculated that deletions in the NA
stalk are associated with the adaptation of influenza viruses to
land-based poultry (11, 14). The avian H5N1 and H9N2 viruses
that were transmitted to humans in 1997 and 1999, respectively,
contained deletions in their NA stalk regions. H5N1 influenza A
viruses with different NA stalk motifs differ in virulence and
pathogenesis in chickens (38). The chicken-adapted H2N2 and
FIG 5 Histopathologic changes in lungs of mice with secondary bacterial pneu-
monia. The images shown are H&E-stained sections of lungs collected at 7 dpi
from BALB/c mice infected with 0.5 MLD50 of PR8 (A), WT H2N2 (B), NA
mutant H2N2 (C), WT H9N2 (D), or NA mutant H9N2 (E) virus. All viruses
carry the PR8 isogenic background. Original magnification,40. (F to M) Mice
were infectedwith the indicated viruses and then challenged at 7 dpiwith 104CFU
of pneumococci. Lungs were collected at 2 dppc. Representative H&E-stained
sections are shown at 200 magnification. (F) Mock-infected mice challenged
with pneumococci. (G) Mice infected with PR8 and then mock challenged with
PBS.Thevirus-S.pneumoniae groups correspond toWTH2N2(H),NAmutant
H2N2 (I), WTH9N2 (J),NAmutant H9N2 (K), and PR8 (L).
FIG 6 Oseltamivir treatment reduces secondary bacterial pneumonia inNA
mutant H2N2 andH9N2 virus-infectedmice.Mice (n 8) were infected with
0.5 MLD50 of the indicated viruses and treated with oseltamivir for 5 days,
starting at 48 hpi, and then challenged at 7 dpi with 104 CFU of S. pneumoniae.
(A) Mean percentage of body weight lost standard deviation. (B) Survival.
(C) At 1 dppc, 4 mice/group were sacrificed to determine bacterial lung titers
expressed as CFU/g of lung homogenate. An asterisk denotes a statistically
significant difference between the WT and NA mutant H9N2 viruses (P 
0.05 by Student t test).
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H9N2 subtypes used here have 27- and 21-aa deletions, respec-
tively, in the stalk region and showedmore efficient replication in
chickens than the parental viruses (8, 29). Since there were no
prior studies looking at the effect of NA stalk length in avian in-
fluenza viruses in promoting secondary bacterial pneumonia, we
examined its effect in the context of H2N2 and H9N2 avian influ-
enza viruses. To avoid confounding factors unrelated to the NA,
we prepared recombinant viruseswithin the context of an isogenic
background derived from the PR8 strain.We found no differences
between the WT and NAmutant viruses in terms of promotion
of secondary pneumococcal pneumonia in mice with respect to
bacterial growth, lung inflammation, and mortality. This is the
case even at a stage at which the viruses appear to have been
cleared from the lungs or at least are at concentrations below the
limit of detection. Significant differences were observed, however,
in mice that received oseltamivir treatment after influenza virus
infection. Mice infected with the PR8 virus or the NA mutant
viruses and then treated with oseltamivir for 5 days starting at 48
dpi showed significant (80 to 100%) improvement in survival fol-
lowing a bacterial challenge. In contrast, mice infected with the
WTH2N2 andH9N2 viruses showed no significant improvement
in survival under the same conditions. There are several consider-
ations that might explain these observations. Although NA activ-
itywas indistinguishable among the different viruses, elution from
turkey red blood cells was delayed in the NA mutant viruses
compared to that of their wild-type counterparts, which suggests
limited accessibility to certain sialic acid substrates, despite
equally active catalytic sites. These results were in accordance with
earlier studies that concluded that there was no apparent relation-
ship between the elution activities of theNAmutant viruses and
their enzymatic activity (3, 6). Another consideration is the virus
inoculum. Even though mice were inoculated with 0.5 MLD50 of
virus, the amount of virus particles representing such a dose of the
PR8 strain (2 log10 EID50) is very different from that of the other
viruses (6 log10 EID50). A larger virus inoculum would translate
into more cells being targeted for infection, and although the rep-
lication of the H2N2 and H9N2 viruses themselves may not be as
effective as that of PR8, the initial production and activity of NA
are expected to be more widespread. It is conceivable that at these
virus doses, deletions in the NA stalk do not affect the virus’s
ability to promote secondary bacterial infections. Only after osel-
tamivir treatment is it then possible to dissect the limitations of
the NAmutant viruses to access and strip off certain sialic acids
that allow the bacteria to establish a foothold. It is important to
note that the course of antiviral treatment that was used in mice
(twice a day for 5 days) resembles the one recommended by the
manufacturer for the treatment of influenza virus infections in
humans. This treatment course may be effective at preventing a
secondary bacterial infection, depending on the initial influenza
virus infective dose.
We observed efficient pulmonary bacterial clearance in naïve
mice at 1 dppc after infection with either small or large bacterial
inocula (102 to 105 CFU). This initial clearance of pneumococci in
naïve mice has been shown to be the result of innate immune
responses fromalveolarmacrophages andneutrophils (18). In our
study, the presence of macrophages and neutrophils was observed
inmice challengedwith pneumococci alone or previously infected
with influenza virus. Earlier studies reported that dysfunction of
neutrophils and macrophages during influenza virus infection,
due to the induction of gamma interferon (IFN-) and type I IFN,
leads to enhanced susceptibility to secondary bacterial infections
(25, 31). Influenza virus-induced inflammation of epithelial,
bronchial, and alveolar lung cells could provide more attachment
sites for bacteria to grow (16). Increased bacterial replication
would lead to pneumonia, which could eventually result in death.
This is consistent with the histopathological changes observed in
human cases during the 1918, 1957, and 1968 pandemics (34).
Mice infected with influenza A viruses alone showed mild-to-
moderate inflammation at 7 dpi, the time of viral clearance. After
a pneumococcal challenge, the inflammation was severe and dif-
fused, involving most of the lobules of the entire lungs of mice in
the PR8 and H2N2 virus groups. However, in groups of mice
infected with H9N2 viruses, lung inflammation was mild to mod-
erate in some lobes and severe in other lobes, ultimately leading to
severe pneumonia and death.
The induction of pro- and anti-inflammatory cytokines and
chemokines during influenza virus infection is thought to en-
hance the susceptibility of influenza virus-infected mice to sec-
ondary bacterial infections. Several studies have shown that cyto-
kine and chemokine production during primary influenza virus
infection can promote both deleterious injury and dysregulation
of the recruitment and function of immune cells required for the
effective clearance of bacterial pathogens (10, 18, 25, 27, 31). At 8
dpi (1 dppc), the cytokine and chemokine (IL-1, IL-6, TNF-,
KC, and MIP-1) levels of mock-infected PBS controls were not
significantly different from those of mice infected with S. pneu-
moniae alone. Increased cytokine/chemokine levels were found at
8 dpi in mice that had received the PR8 virus alone and then a
mock challenge with PBS. However, exacerbation of these re-
sponses was clearly evident in the virus-infected groups challenge
with pneumococci. We found that at 1 dppc, the coinfected mice
had significantly higher levels of TNF-, IL-6, IL-1, KC, and
MIP-1 than the control groups. KC and MIP-1 are chemoat-
tractant molecules that enhance the recruitment of neutrophils
andmacrophages to the site of inflammation (4). The elevated KC
and MIP-1 levels observed in the coinfected mice should have
enhanced the recruitment of neutrophils and macrophages and
cleared the secondary bacterial infection. However, we observed
severe pneumonia and death in these animals, which may have
been due to acute inflammatory tissue damage in the lungs caused
by these activated leukocytes (33). In contrast, we observed mod-
est increases in IL-10 levels after a bacterial challenge but only in
mice that had been previously infected with PR8 or theWTH9N2
virus. Based on our data, the increased lethality of S. pneumoniae
infection seen after 7 days of influenza virus infection may be due
to dysfunctional alveolar macrophages and neutrophils. The ex-
aggerated cytokine responses seen in ourmodel of secondary bac-
terial pneumonia are likely responsible for the severity of the dis-
ease and the rapid death seen.
In the 20th century, three human influenza pandemics oc-
curred, in 1918 (H1N1), 1957 (H2N2), and 1968 (H3N2), causing
significant mortality (34). In April 2009, a novel, swine-derived
influenza H1N1 virus (pH1N1) caused the first influenza pan-
demic of the 21st century. Importantly, during these pandemics, a
large proportion of the deaths that occurred were attributable to
secondary bacterial respiratory infections. We have previously
shown that reassorted viruses carrying the H9N2 virus surface
genes in the seasonal human H3N2 and pH1N1 viruses were effi-
ciently transmitted via respiratory droplets in ferrets (9, 30). Also,
Sun et al. showed that the reassortants derived from avian H9N2
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and pH1N1 viruses were more pathogenic in mice than both pa-
rental viruses were (32). In this context, the present study high-
lights the importance of avian influenza viruses (H2N2 and
H9N2)with orwithout a deletion in theNAgene and its role in the
superinfection of mice with S. pneumoniae.
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